MondegarAI
ACT CAPITAL MANAGEMENT, LLC

Q1 2022 · 13F-HR

ACT CAPITAL MANAGEMENT, LLCholdings as filed

Filed 2022-05-11 · accession 0001636587-22-000009

$94,516
Reported value
85
Positions
2022-03-31
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
852312305STAASTAAR SURGICAL CO$19,02720.1%238,100CommonSOLE
04280A100ARWRARROWHEAD PHARMACEUTICALS INC$9,2449.78%201,000CommonSOLE
03969T109ARCTARCTURUS THERAPEUTICS HLDGS$6,8297.23%253,300CommonSOLE
185063104CLSDUSDCLEARSIDE BIOMEDICAL INC$5,6305.96%2,458,600CommonSOLE
67066G104NVDANVIDIA CORPORATION$4,2294.47%15,500CommonSOLE
501147102KRYSKRYSTAL BIOTECH INC$3,9264.15%59,000CommonSOLE
M85548101SSYSSTRATASYS LTD$3,5173.72%138,500CommonSOLE
25179M103DVNDEVON ENERGY CORP NEW$2,6312.78%44,500CommonSOLE
29415J106ENVVENO MED CORP$2,5562.70%401,200CommonSOLE
516544103LNTHLANTHEUS HOLDINGS INC$2,2122.34%40,000CommonSOLE
28249U105CLDNEUREIGER BIOPHARMACEUTICALS INC$2,0752.20%250,000CommonSOLE
45782T105INMBINMUNE BIO INC$1,9412.05%230,500CommonSOLE
45166A102IDYAIDEAYA BIOSCIENCES INC$1,9412.05%173,500CommonSOLE
45719W106INHIBIKASE THERAPEUTICS INC$1,5931.69%1,076,500CommonSOLE
00738A106ADTRAN INC$1,5681.66%85,000CommonSOLE
25402D102DOCNDIGITALOCEAN HLDGS INC$1,4461.53%25,000CommonSOLE
009496100AIRSAIRSCULPT TECHNOLOGIES INC$1,3891.47%101,500CommonSOLE
N01045108AFFIMED N V$1,3491.43%308,800CommonSOLE
44934S206ICADUSDICAD INC$1,3131.39%294,500CommonSOLE
35953D104FUBOGBPFUBOTV INC$1,2611.33%192,000CommonSOLE
74760R303QUALTEK SERVICES INC$1,1371.20%354,269CommonSOLE
G637AM102MYOVANT SCIENCES LTD$1,1321.20%85,000CommonSOLE
04537Y109ASPIRA WOMENS HEALTH INC$1,0401.10%1,000,000CommonSOLE
98956A105ZETAZETA GLOBAL HOLDINGS CORP$9240.98%72,500CommonSOLE
75281A109RRCRANGE RESOURCES CORP$9110.96%30,000CommonSOLE
05156V102AUPHAURINIA PHARMACEUTICALS INC$8360.88%67,500CommonSOLE
023135106AMZNAMAZON.COM INC$6520.69%200CommonSOLE
91680M107UPSTUPSTART HLDGS INC$6000.63%5,500CommonSOLE
19260Q107COINCOINBASE GLOBAL INC$5700.60%3,000CommonSOLE
166764100CVXCHEVRON CORP NEW$5700.60%3,500CommonSOLE
632307104NTRANATERA INC$5090.54%12,500CommonSOLE
15870P307CSBRCHAMPIONS ONCOLOGY INC$5080.54%62,500CommonSOLE
86877M209SURFACE ONCOLOGY INC$5010.53%170,500CommonSOLE
68235C107ONCOCYTE CORPORATION$4920.52%330,000CommonSOLE
52187K101LEAP THERAPEUTICS INC$4640.49%265,000CommonSOLE
M5216V106GLBEGLOBAL-E ONLINE LTD$4220.45%12,500CommonSOLE
09075P105BTAIEURBIOXCEL THERAPEUTICS INC$4180.44%20,000CommonSOLE
64049K104NEOLEUKIN THERAPEUTICS INC$3740.40%199,000CommonSOLE
70465T107PDSBPDS BIOTECHNOLOGY CORP$3710.39%60,000CommonSOLE
577096100MTTR*MATTERPORT INC$3250.34%40,000CommonSOLE
00827B106AFRMAFFIRM HLDGS INC$3240.34%7,000CommonSOLE
26142Q205DRAGANFLY INC$3210.34%135,000CommonSOLE
76243J105RYTMRHYTHM PHARMACEUTICALS INC$3170.34%27,500CommonSOLE
68236P107GTXIEURONCTERNAL THERAPEUTICS INC$3130.33%225,000CommonSOLE
N44445109IMTXIMMATICS N V$3000.32%37,500CommonSOLE
14147L108CRDFCARDIFF ONCOLOGY INC$2990.32%120,600CommonSOLE
05070N103AUDACY INC$2820.30%97,500CommonSOLE
G11196105BIOHAVEN PHARMACEUTICAL HLDG CO LTD$2490.26%2,100CommonSOLE
39868T1052JQGRITSTONE BIO INC$1960.21%47,500CommonSOLE
58490H107MDNAFMEDICENNA THERAPEUTICS CORP$1950.21%152,500CommonSOLE
231269200CURIS INC$1900.20%80,000CommonSOLE
00653A107ADAPYADAPTIMMUNE THERAPEUTICS PLC$1850.20%90,000CommonSOLE
54570M108LOTTERY COM INC$1760.19%56,000CommonSOLE
60800C109MOGO INC$1600.17%55,000CommonSOLE
69242L106OYSTOYSTER PT PHARMA INC$1570.17%13,500CommonSOLE
57055L107MARKER THERAPEUTICS INC$1560.17%354,400CommonSOLE
15117F500CELLECTAR BIOSCIENCES INC$1500.16%217,500CommonSOLE
00973W102AKERNA CORP$1460.15%128,000CommonSOLE
89357L105TRANSCODE THERAPEUTICS INC$1440.15%50,000CommonSOLE
00973Y108AKROAKERO THERAPEUTICS INC$1420.15%10,000CommonSOLE
M4130Y106ENLVENLIVEX THERAPEUTICS LTD$1400.15%25,000CommonSOLE
03209T109AMPIO PHARMACEUTICALS INC$1370.14%291,500CommonSOLE
12482W101CBDMD INC$1300.14%125,000CommonSOLE
42328V603HELIUS MED TECHNOLOGIES INC$1170.12%35,263CommonSOLE
23283X206CTSOCYTOSORBENTS CORP$1120.12%35,000CommonSOLE
45783C101INSTIL BIO INC COM$1080.11%10,000CommonSOLE
829399104SIO GENE THERAPIES INC$980.10%146,500CommonSOLE
868153107SDPIUSDSUPERIOR DRILLING PRODS INC$850.09%80,000CommonSOLE
046513107ATRAGBXATARA BIOTHERAPEUTICS INC$850.09%9,200CommonSOLE
78472W104SQZBSQZ BIOTECHNOLOGIES CO$770.08%16,000CommonSOLE
89237H209TRACON PHARMACEUTICALS INC$750.08%28,500CommonSOLE
05337M104AVADEL PHARMACEUTICALS PLC$720.08%10,500CommonSOLE
54570M116LTRYWLOTTERY COM INC$610.06%125,000CommonSOLE
98459U103YALAYALLA GROUP LTD$600.06%13,500CommonSOLE
23284P103CYTEIR THERAPEUTICS INC$570.06%15,000CommonSOLE
09071M205BIOLINE RX LTD$470.05%27,500CommonSOLE
03828A101APLTAPPLIED THERAPEUTICS INC$420.04%20,000CommonSOLE
87184Q107SYROS PHARMACEUTICALS INC$420.04%35,000CommonSOLE
03890D108VSAREURARAVIVE INC$340.04%17,500CommonSOLE
00507W206ATNMACTINIUM PHARMACEUTICALS INC$330.03%6,500CommonSOLE
640268108NKTREURNEKTAR THERAPEUTICS$320.03%6,000CommonSOLE
37186H100GENETRON HOLDINGS LIMITED$160.02%7,500CommonSOLE
009066101ABNBAIRBNB INC$90.01%50CommonSOLE
372427401GNCAQGENOCEA BIOSCIENCES INC$60.01%5,000CommonSOLE
053734885AVINGER INC$60.01%1,751CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.